Intracranial metastatic disease is rarely found in head and neck cancer (HNC), in particular, cavernous sinus (CS) involvement is difficult to recognize, because of its rarity, not specific symptoms associated and challenging imaging features. We report our experience in 4 cases, reviewing also the English literature. We analysed data from 21 patients showing that CS metastasis is a dramatic event, with rapid onset, usually starting with neurological manifestations (ophthalmoplegia, headache and trigeminal dysesthesia) and almost unavoidable outcome (DOD in 18/21 patients). Furthermore, we assessed that the diagnostic confirmation could be difficult to perform because of the need for multiple exams and time consuming procedures. Unfortunately, usual antineoplastic therapies seem to be not effective in prolonging survival, also because patients are already weakened by primary tumour treatments. The only option that seems useful in improving outcomes is immunotherapy.

Cavernous sinus metastasis in head and neck cancer: Focus on oral squamous cell cancer / E. Segna, F. Civita, N. Denaro, G.A. Beltramini. - In: ORAL ONCOLOGY. - ISSN 1368-8375. - 152:(2024), pp. 106784.1-106784.3. [10.1016/j.oraloncology.2024.106784]

Cavernous sinus metastasis in head and neck cancer: Focus on oral squamous cell cancer

F. Civita;G.A. Beltramini
Ultimo
2024

Abstract

Intracranial metastatic disease is rarely found in head and neck cancer (HNC), in particular, cavernous sinus (CS) involvement is difficult to recognize, because of its rarity, not specific symptoms associated and challenging imaging features. We report our experience in 4 cases, reviewing also the English literature. We analysed data from 21 patients showing that CS metastasis is a dramatic event, with rapid onset, usually starting with neurological manifestations (ophthalmoplegia, headache and trigeminal dysesthesia) and almost unavoidable outcome (DOD in 18/21 patients). Furthermore, we assessed that the diagnostic confirmation could be difficult to perform because of the need for multiple exams and time consuming procedures. Unfortunately, usual antineoplastic therapies seem to be not effective in prolonging survival, also because patients are already weakened by primary tumour treatments. The only option that seems useful in improving outcomes is immunotherapy.
Cavernous sinus; Head and neck cancer; Immunotherapy; Metastasis; Neurologic manifestations; Ophtalmoplegia; Oral cancer
Settore MEDS-15/B - Chirurgia maxillo-facciale
2024
Article (author)
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S1368837524001027-main.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 331.03 kB
Formato Adobe PDF
331.03 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1132766
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
  • OpenAlex ND
social impact